Month: April 2024

Boca Raton, Florida, April 25, 2024 (GLOBE NEWSWIRE) —  INmune Bio, Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, today announced today that it has entered into definitive agreements for the sale and purchase of 986,000 shares of its common stock and warrants to purchase up to an aggregate of 986,000 shares of its common stock at an offering price of $9.84 per share of common stock and accompanying warrant. The warrants include an acceleration clause upon positive top-line data in the Company’s Phase 2 Alzheimer’s Disease program (as further described  below).  The offering was priced at-the-market under Nasdaq rules based on the average of the previous 5-days’ closing prices, or $9.84 per share which includes...

SANTA PAULA, Calif., April 25, 2024 (GLOBE NEWSWIRE) — Calavo Growers, Inc. (Nasdaq: CVGW) (“Calavo” or the “Company”), a global avocado industry leader and provider of convenient, ready-to-eat fresh food, yesterday at its Annual Meeting of Shareholders said in a business update that:The Company has made significant progress toward completing the proposed sale of the Fresh Cut business (formerly “RFG”) and related real property and expects to close in May 2024 As previously shared, the expected uses of sale proceeds would include paying down debt and returning cash to shareholders The Company’s internal investigation into potential Foreign Corrupt Practices Act violations in Mexico is winding down and the Company will share more with investors when it is able to do soAbout Calavo Growers, Inc. Calavo Growers, Inc. (Nasdaq:...

MELBOURNE, Australia and PRINCETON, N.J., April 25, 2024 (GLOBE NEWSWIRE) — Opthea Limited (ASX/NASDAQ: OPT “Opthea”, the “Company”), a clinical-stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, including wet age-related macular degeneration, today announced that Dr. Frederic Guerard, Chief Executive Officer (CEO) of Opthea, will present the Company’s clinical-stage pipeline, as well as its innovation agenda, at the OIS Retina Innovation Summit prior to the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting on May 4, 2024 in Seattle, Washington. OIS Retina Innovation Summit DetailsSession Innovation ShowcaseDate: Saturday, May 4, 2024Time: 8:35 to 9:50 a.m. PDTPresenter: Frederic Guerard, PharmD, CEOAbout Opthea Opthea (ASX/NASDAQ:OPT)...

Planegg/Martinsried, April 25, 2024. Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies for solid tumors, today presents a comprehensive overview of its lead candidate MDG1015, a first-in-class 3rd generation T cell receptor engineered T cell (TCR-T) therapy, at CHI’s 8th Annual Immuno-Oncology Summit Europe from April 23-25, 2024, in London. MDG1015, which is advancing towards the clinic, targets NY-ESO-1 / LAGE-1a (New York esophageal squamous cell carcinoma 1 / L Antigen Family Member-1a) and is armored and enhanced by the PD1-41BB costimulatory switch protein The presentation with the title “MDG1015: a 3rd Generation TCR-T Therapy Incorporating the PD1-41BB Costimulatory Switch Protein, Advancing to the Clinic”...

LOS ANGELES, April 25, 2024 (GLOBE NEWSWIRE) — Hanmi Financial Corporation (NASDAQ: HAFC, or “Hanmi”), the parent company of Hanmi Bank (the “Bank”), today announced that its Board of Directors declared a cash dividend on its common stock for the 2024 second quarter of $0.25 per share. The dividend will be paid on May 22, 2024, to stockholders of record as of the close of business on May 6, 2024. In addition, the Board of Directors today approved a new stock repurchase program. Under the new repurchase program, the Company may repurchase up to 5% of its outstanding shares, or approximately 1.5 million shares of its common stock. “We believe Hanmi’s long-term growth prospects are attractive, and today’s new share repurchase authorization serves as evidence of the Company’s ongoing focus on its capital allocation priorities”, said...

AUSTIN, Texas, April 25, 2024 (GLOBE NEWSWIRE) — Phunware, Inc. (NASDAQ: PHUN) (“Phunware” or “the Company”), the leading provider of patented wayfinding and mobile engagement solutions that enable brands to engage, manage and monetize anyone anywhere, will hold a conference call on Thursday, May 9, 2024, at 4:30 p.m. Eastern time (1:30 p.m. Pacific time) to discuss its financial results for the first quarter ended March 31, 2024. Financial results will be issued in a press release prior to the call. Phunware management will host the conference call, followed by a question and answer period. Date: Thursday, May 9, 2024Time: 4:30 p.m. Eastern time (1:30 p.m. Pacific time)U.S. dial-in: 888-506-0062International dial-in: 973-528-0011Access Code: 694812 Please call the conference telephone number 10 minutes prior to the start time....

MONTREAL, April 25, 2024 (GLOBE NEWSWIRE) — Supremex Inc. (“Supremex” or the “Company”) (TSX: SXP), a leading North American manufacturer and marketer of envelopes and a growing provider of paper-based packaging solutions, will release its results for the first quarter ended March 31, 2024, after markets close Wednesday, May 8, 2024. A conference call to discuss these results will be held on Thursday, May 9, 2024, at 8:30 a.m. (Eastern Time). Conference Call: A live broadcast of the Conference Call will be available on the Company’s website, in the Investors section under Webcast. To participate (professional investment community only) or to listen to the live conference call, please dial the following numbers. We suggest that participants call-in at least 5 minutes prior to the scheduled start time:  • Confirmation number: 10023227  •...

No-compromise, next-gen GaN and SiC technologies drive faster EV charging, longer range and lower system costsNavitas Highlights EV High-speed Hybrid Power Semiconductor Advances in China Innovation Summit KeynoteNo-compromise, next-gen GaN and SiC technologies drive faster EV charging, longer range and lower system costsTORRANCE, Calif., April 25, 2024 (GLOBE NEWSWIRE) — Navitas Semiconductor (Nasdaq: NVTS), the industry leader in next-generation GaNFast™ gallium nitride (GaN) and GeneSiC™ silicon carbide (SiC) power semiconductors, today announced its participation in forthcoming China Electronic Hotspot Solutions Innovation Summit in Shenzhen on April 27th. The summit gathers key players in power semiconductors and associated customer design teams for innovations in EV such as 800 V supercharging,...